We are all constantly bombarded with diet and exercise tips, plans and programs and with so much information and advice to wade through many people simply throw up their hands in confusion as it all seems too hard. With so much so called 'expert' information around you would think we should all be slim and trim. No so, two thirds of us are now considered overweight and our collective risk of the many deadly and costly diseases keeps...more
Strategic sourcing is an institutional procurement process that continuously improves and re-evaluates the purchasing activities of a company. In a production environment, it is often considered one component of supply chain management. Strategic sourcing techniques are also applied to non traditional area such as services or capital.Outsourcing often refers to the process of contracting to a third-party. While outsourcing may be viewed as a...more
MolMed S.p.A. (MLM) - Financial and Strategic Analysis ReviewMolMed S.p.A. (Molmed) is a biotechnology company, engaged in the research, development and clinical validation of new therapies for the treatment of cancer. Its product pipeline includes NGR-hTNF, NGR-IFNg and NGR-IL12. Its lead drug candidate, NGR-hTNF is undergoing Phase III clinical development both as monotherapy and in combination therapy, in a total of six indications. It has been granted Orphan Drug designation in the European Union and in the US. NGR-IFNg is a novel therapeutic candidate which is in pre clinical stage. Its investigational drug candidate, NGR-IL12 is in R&D stage.This comprehensive SWOT profile of MolMed S.p.A. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.This company report forms part of the Profile on Demand service, covering over 50,000 of the...more
Sinovac Biotech Ltd. (SVA) - Financial and Strategic Analysis ReviewSinovac Biotech Ltd. engages in the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases including hepatitis A, seasonal influenza, H5N1 (bird flu) pandemic influenza and H1N1 influenza. Sinovac was the first company...more
Velcera, Inc. (VLCR) - Financial and Strategic Analysis ReviewVelcera, Inc. (Velcera) is a is a development stage specialty pharmaceutical company, engaged in the acquisition, development and commercialization of pharmaceutical products for the pet health market. Velcera is focused on developing pet medicines in pain management, anti-allergy and...more
Viral Genetics, Inc. (VRAL) - Financial and Strategic Analysis ReviewViral Genetics, Inc. (Viral Genetics) is a biotechnology company, engaged in the discovery, development and commercialization of immune based therapies using its thymus nuclear protein compound for the treatment of serious diseases and autoimmune conditions. Viral Genetics is focused on developing therapies to treat HIV/AIDS and other infectious, autoimmune, and immunological deficiency disorders. The lead product candidate of Viral Genetics is VGV-1, which is being studied in clinical trials for the treatment for HIV infection and AIDS. The company is headquartered in San Marino, California, the US.Viral Genetics, Inc. Key Recent DevelopmentsApr 19, 2010: Viral Genetics Opens Lab In TexasDec 08, 2009: Viral Genetics Enters Into Exclusive License Agreement With University of ColoradoMar 18, 2009: Viral Genetics Receives Grant From TTC For Lyme Research StudyThis comprehensive SWOT profile of Viral Genetics, Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and...more
Cordex Pharma, Inc. (CDXP) - Financial and Strategic Analysis ReviewCordex Pharma, Inc. (Cordex Pharma) is a pharmaceutical company that develops therapeutic and diagnostic products. It also develops cardiovascular medicines that are based upon the...more
Myriad Pharmaceuticals, Inc. (MYRX) - Financial and Strategic Analysis ReviewMyriad Pharmaceuticals, Inc. (Myriad Pharmaceuticals) is a pharmaceutical company, engaged in the discovery, development, and commercialization of small molecule drug...more
Earlier, buying a Digital Video Disc player meant causing a deep hole in your purse. Not so anymore, as today they are available at a fraction of their earlier amount. As a matter of fact, Wholesale DVDs are now available for a minimum of $25, which...more
Genexine Co., Ltd. (95700) - Financial and Strategic Analysis ReviewGenexine Co., Ltd. (Genexine) is involved in the research and development of therapeutic vaccines for incurable diseases and next-generation antibody fusion protein drugs such as...more
Propharex (PROP) - Financial and Strategic Analysis ReviewPropharex is a specialty pharmaceutical company specialized in the conception, the construction, the delivery and the assembly of "turnkey" modular pharmaceutical plants. The company supplies...more
Zhongtian International Limited (2379) - Financial and Strategic Analysis ReviewZhongtian International Limited (Zhongtian International) is an investment holding company engaged in trading of software and hardware products. The company also offers...more